AMBUJACEM stock
AMBUJACEM is in a mixed news setup around Cement; 11 recent stories are active but the saved quote move at +0.00% keeps the read balanced.
AMBUJACEM has built a mixed coverage cluster in the last 23 days. The strongest recurring theme is Cement, while the current weighted impact score is -2 from 3 bullish, 7 bearish, and 1 neutral stories across 4 sources.
AMBUJACEM is last saved at ₹405 with a day move of +0.00%. That quote should be read with the article tape: a positive headline only matters if price, volume, and follow-through confirm it; a negative headline matters more when it keeps repeating across multiple publishers.
This is a record of AMBUJACEM's latest financial filing. We don't have previous quarter's data to compare, so we can't say if things improved or weakened. This information helps you understand the company's financial health. This hub keeps the permanent stock view separate from short-lived article pages, so search engines and users get one accumulated view instead of scattered programmatic summaries.
Economic Times · 30 Jul 2026 · 2 min read
Economic Times · 29 Jul 2026 · 2 min read
Mint · 28 Jul 2026 · 2 min read
Mint · 28 Jul 2026 · 2 min read
Economic Times · 28 Jul 2026 · 2 min read
How AMBUJACEM stacks against related names in this news cluster
AMBUJACEM has appeared across 11 recent stories from 4 sources, which usually means there is a real flow of fresh headlines rather than a single isolated mention.
AMBUJACEM coverage is currently leaning bearish, with 3 bullish, 7 bearish, and 1 neutral analyzed stories in the recent window.
Recent AMBUJACEM coverage is clustering around Cement and Construction Materials. Related names showing up alongside AMBUJACEM include ULTRACEMCO, ACC, SHREECEM.
Use this page as a coverage hub for AMBUJACEM: start with the latest headlines, then check the dominant themes, related names, and saved market context before you form a trade or watchlist view.
10 recent mentions linked to AMBUJACEM
TopicConstruction Materials7 recent mentions linked to AMBUJACEM
StockULTRACEMCORelated news cluster with 6 links
Latest storyBearish for AMBUJACEM: Q1 Net Profit Down 37% on Volume & Cost WoesThe cement sector is grappling with high input costs (fuel, logistics) and potentially softer demand
How retail crowds and channels are talking about AMBUJACEM right now — context for your own research, not a trade call.